Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bioasis Technologies Inc. V.BTI

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a multi-asset rare and orphan disease biopharmaceutical company developing clinical stage programs based on epidermal growth factors and the xB3™ platform, a proprietary technology for the delivery of therapeutics across the blood brain barrier and the treatment of CNS disorders in areas of high unmet medical need. The in-house development programs are designed to develop symptomatic and disease-modifying treatments for brain-related diseases and disorders.


TSXV:BTI - Post by User

Comment by regardlesson Sep 23, 2020 3:04pm
189 Views
Post# 31605575

RE:RE:RE:Thanks for the people/firms that bought this morning...

RE:RE:RE:Thanks for the people/firms that bought this morning...I like
dr rathjen a lot.. she doesn't mess about and you can tell
shes all buisiness... I thought that to with mark day but was wrong... however unlike one another they may be , the company still
has major issues creating hype, media attention and mainstream article submissions, and that keeps us stagnant even with a chiesi blockbuster deal.

we need more awareness about the company, what it does, and the people behind it, 
these doctors  and delivery system needs to be viewed as larger than life 
that's when things go parabolic 
<< Previous
Bullboard Posts
Next >>